Survival prognoses of Heng intermediate-risk patients with metastatic renal cell carcinoma treated with immunotherapy or targeted therapy: A real-world, single-center retrospective study
published in: Investigative and clinical urology
date of publication: 2020-02-13
main subject: immunotherapy, metastatic renal cell carcinoma
Cites articles 28
- 2017-05-24
Date
Title
Article - wd:Q90223295